封面
市場調查報告書
商品編碼
2039033

葡萄糖注射劑市場:依產品類型、應用、通路和地區分類

Dextrose Injection Market, By Product Type, By Application, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到2026年,葡萄糖注射液市場規模將達到61.4億美元,2033年將達到90.5億美元。預計從2026年到2033年,其複合年成長率將達到5.7%。

分析範圍 分析詳情
基準年 2025 市場規模(2026 年) 61.4億美元
效能數據 2020-2024 預測期 2026-2033
預測期(2026-2033 年)複合年成長率 5.70% 預計金額(2033 年) 90.5億美元

葡萄糖注射液可提供液體和熱量,並可能根據患者的臨床狀況產生利尿作用。葡萄糖注射液無菌、無熱原,且不含抑菌劑或抗菌劑。本品僅供靜脈注射。此靜脈輸注液適用於成人和兒童患者,可作為補充水分和熱量的來源。葡萄糖注射液的劑量取決於患者的年齡、體重、臨床狀況和實驗室檢查結果。

市場動態

預計在預測期內,全球注射用葡萄糖市場成長將受到以下因素的推動:新產品上市和核准的增加;市場主要參與者擴大採用非內部成長策略,例如合作和收購;以及重症監護中對快速起效的緊急營養療法——葡萄糖的需求不斷成長。例如,2015年7月,B. Braun Medical Inc.獲得了美國食品藥物管理局(FDA)的核准,其2公升裝的70%注射用葡萄糖溶液獲得批准。

本報告的主要特點

  • 本報告揭示了各個細分市場的潛在商機,並描述了該市場中一系列有吸引力的投資提案。
  • 此外,它還提供了有關市場促進因素和限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要公司採取的競爭策略的重要見解。
  • 本文根據以下參數,介紹了全球葡萄糖注射液市場主要公司的概況:公司概況、產品系列、主要亮點、財務表現和策略。
  • 本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、產品線更新、市場擴張和行銷策略做出明智的決策。
  • 《全球葡萄糖注射液市場》報告面向該行業的各種相關人員,包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 相關人員可以透過分析全球葡萄糖注射液市場中使用的各種策略矩陣來促進決策。

目錄

第1章:分析目標與假設

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機遇
  • 影響分析
  • 市場趨勢
  • 主要進展
  • 產品核准
  • 合作關係、併購
  • 監理情勢
  • PEST分析
  • 波特五力分析
  • 流行病學
  • 強大的管道分析

第4章:全球葡萄糖注射劑市場:依產品類型分類(2021-2033 年)

  • 5%葡萄糖注射液
  • 10%葡萄糖注射液
  • 50%葡萄糖注射液
  • 70%葡萄糖注射液
  • 其他

第5章:全球葡萄糖注射液市場:依應用領域分類(2021-2033年)

  • 急救
  • 運動的
  • 營養療法
  • 其他

第6章:全球葡萄糖注射液市場:依通路分類(2021-2033 年)

  • 醫院藥房
  • 零售藥房
  • 網路藥房

第7章 全球葡萄糖注射液市場:依地區分類(2021-2033 年)

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 亞太其他地區
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 中非
    • 南非

第8章 競爭情勢

  • 熱圖分析
  • 市佔率分析
  • 公司簡介
    • Pfizer Inc
    • Amphastar Pharmaceuticals Inc
    • Shangai Haixin group Co. Ltd
    • Seqirus GmbH
    • Baxter International Inc
    • Shandong Qidu Pharmaceutical
    • Sanctus drugs and pharmaceuticals Pvt
    • Hospira Inc
    • B Braun Medical Ltd
    • Aurobindo Pharmaceuticals Ltd
    • SteriMAx Inc

第9章

  • 參考
  • 分析方法
  • 關於本公司
簡介目錄
Product Code: CMI1835

Dextrose Injection Market is estimated to be valued at USD 6.14 Bn in 2026 and is expected to reach USD 9.05 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.7% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 6.14 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 5.70% 2033 Value Projection: USD 9.05 Bn

Dextrose injection contain source of water and calories, and is capable of inducing diuresis depending on the clinical condition of the patient. Dextrose injections are sterile, non-pyrogenic, and does not contain bacteriostatic or antimicrobial agents. It is intended for intravenous administration. This intravenous solution is indicated for use in adults and pediatric patients as sources of calories and water for hydration. Dosage of dextrose injection is dependent upon the age, weight, and clinical condition of the patient as well as laboratory determinations.

Market Dynamics

Increasing launches and approval of novel products, increasing adoption of inorganic growth strategies such as collaboration and acquisition by key players operating in the market and rising demand for dextrose for first-aid treatment as instant nutrition therapy in critical care are expected to drive the growth of global dextrose injection market over the forecast period. For instance, in July 2015, B. Braun Medical Inc. received the U.S. Food and Drug Administration approval for 70% Dextrose for Injection in a 2L flexible container.

Key features of the study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global dextrose injection market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Pfizer Inc., Amphastar Pharmaceuticals Inc., Shangai Haixin group Co. Ltd., Seqirus GmbH, Baxter International Inc., Shandong Qidu Pharmaceutical, Sanctus drugs and pharmaceuticals Pvt., Hospira Inc., B Braun Medical Ltd., Aurobindo Pharmaceuticals Ltd., and SteriMAx Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global dextrose injection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global dextrose injection market

Market Segmentation

  • By Product Type
    • 5% Dextrose Injection
    • 10% Dextrose Injection
    • 50% Dextrose Injection
    • 70% Dextrose Injection
    • Others
  • By Application
    • First-aid Treatment
    • Sports
    • Trophotherapy
    • Others
  • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Dextrose Injection Market, By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • Central Africa
    • North Africa
  • Key Players
    • Pfizer Inc
    • Amphastar Pharmaceuticals Inc
    • Shangai Haixin group Co Ltd
    • Seqirus GmbH, Baxter International Inc
    • Shandong Qidu Pharmaceutical
    • Sanctus drugs and pharmaceuticals Pvt
    • Hospira Inc., B Braun Medical Ltd
    • Aurobindo Pharmaceuticals Ltd
    • SteriMAx Inc

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By Application
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Product Approval
  • Collaboration/Merge/Acquisition
  • Regulatory Landscape
  • PEST Analysis
  • Porter's Five Forces Analysis
  • Epidemiology
  • Robust Pipeline Analysis

4. Global Dextrose Injection Market, By Product Type, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022- 2033
    • Segment Trends
  • 5% Dextrose Injection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • 10% Dextrose Injection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • 50% Dextrose Injection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • 70% Dextrose Injection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Dextrose Injection Market, By Application, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • First-aid Treatment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Sports
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Trophotherapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Dextrose Injection Market, By Distribution Channel, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Dextrose Injection Market, By Region, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2022-2033
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
  • Company Profile
    • Pfizer Inc
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Amphastar Pharmaceuticals Inc
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Shangai Haixin group Co. Ltd
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Seqirus GmbH
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Baxter International Inc
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Shandong Qidu Pharmaceutical
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Sanctus drugs and pharmaceuticals Pvt
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Hospira Inc
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • B Braun Medical Ltd
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Aurobindo Pharmaceuticals Ltd
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • SteriMAx Inc
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
  • Analyst Views

9. Section

  • References
  • Research Methodology
  • About Us